Journal News

JBC: A change in labs reveals a key to cataract formation

Researchers studying lens crystallin proteins describe how two types of damage interact
Laurel Oldach
April 01, 2019

Researchers working to understand the biochemistry of cataract formation have made a surprising finding: A protein that was long believed to be inert has an important chemical function that protects the lens of the eye from cataracts.

Acela train Though the labs where Eugene Serebryany did his graduate and postdoctoral research were just two stops apart on the subway, he had trouble replicating his experiments when he moved. Figuring out what had changed led to a discovery in cataract formation. Acela 2038/Wikipedia

The lens is made up of cells packed with structural proteins called crystallins that form a dense gel. The gel’s optical properties — such as its transparency and the way it refracts light — help focus light onto the retina. But when crystallin proteins clump together, they scatter incoming light, forming cloudy deposits known as cataracts.

According to Harvard postdoctoral fellow Eugene Serebryany, lead author on a study in the Journal of Biological Chemistry, researchers long believed that crystallin proteins were chemically inert; except for aggregating over time, the proteins were not supposed to interact much with other proteins.

As a graduate student at the Massachusetts Institute of Technology, Serebryany used a mutant form of gamma-crystallin to mimic the damage ultraviolet light causes the protein. While studying how that mutation leads crystallin to clump up, Serebryany found something surprising: The mutant was more likely to aggregate if wild-type, or undamaged, protein was also present.

Eugene Shakhnovich of Harvard, who collaborated with Serebryany and his graduate adviser, Jonathan King, on the earlier studies, described the finding as “fairly striking.”

“If you had these damaged proteins in a test tube, they would not aggregate for a while,” Shakhnovich said. “If you had the wild-type protein, it would not aggregate forever. But then, when you mix the two, you see rapid and precipitous aggregation.”

Somehow, the healthy version of a protein everyone had thought was inert was causing a slightly damaged version to get much worse — and fast. Shakhnovich hired Serebryany at Harvard to continue studying how a supposedly inactive protein could cause this effect.

But Serebryany had trouble replicating the results of his own experiments. “It’s a different place, it’s a different set of instruments, a slightly different set of procedures. You see where this is going,” he said. “All of a sudden, experiments that were highly reproducible before were giving a lot of variability.”

In the Harvard lab, the wild-type crystallin sometimes caused mutant crystallin to aggregate, and sometimes it didn’t.

“Obviously, if there is suddenly variability, there is a hidden variable that we didn’t see before,” Serebryany said. He set up a series of experiments to try to pinpoint that variable.

Close comparison of the molecular weights of batches of the wild-type protein that caused or failed to cause the mutant to clump revealed a difference equivalent to the weight of two hydrogen atoms. This gave the researchers a hint that the protein’s redox state — whether two sulfur atoms were bound to one another or to hydrogen atoms — made a difference.

“By carrying out isotopically resolved mass spectrometry experiments, we got more than we bargained for,” Serebryany said. “Not only did the aggregation-prone mutant acquire one internal disulfide bond per molecule during the aggregation reaction, but the aggregation-promoting wild-type protein lost its disulfide at the same time.”

By mutating crystallin’s sulfur-containing cysteine amino acid residues one by one, Serebryany found that two residues close together on the surface of the protein acted as a kind of switch. When they bound, forming a disulfide bond, crystallin was able to push damaged molecules toward aggregation. When each was bound to a hydrogen atom, wild-type crystallin was inert.

How could one bond between amino acids on the surface of this protein make it drive other proteins to aggregate?

The team found that although the disulfide bond forms easily, it strains the protein’s structure. This made each molecule likely to pass along the disulfide bond to another nearby, receiving two protons in return. In this way, the disulfide bond could be passed constantly around among crystallin protein molecules like a hot potato.

Given a whole population of undamaged crystallin proteins, that could go on indefinitely. But if one protein was already a little damaged, the authors showed, it caught the hot potato with a different set of cysteines, which were less able to pass it on. This drove the damaged protein to aggregate.

According to Shakhnovich, the team is working on peptide treatments that might keep the hot potato from reaching damaged proteins. Serebryany hopes such peptides “could actually soak up some of those disulfides and delay the time that it takes to form the more aggregation-prone species.”

That could lead to slower cataract formation for patients.

Laurel Oldach

Laurel Oldach is a science writer for the ASBMB.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

'Every experiment and every breakthrough matters'
Health Observance

'Every experiment and every breakthrough matters'

February 26, 2021

An interview with NYMC dean Marina K. Holz, who studies a rare disease that affects women of childbearing age.

Progeria: From the unknown to the first FDA-approved treatment
Health Observance

Progeria: From the unknown to the first FDA-approved treatment

February 25, 2021

Hutchinson–Gilford progeria syndrome is a rare, fatal genetic disease that causes premature aging.

Raising awareness and funding for Pompe disease
Health Observance

Raising awareness and funding for Pompe disease

February 25, 2021

Father-turned-advocate has founded multiple organizations to support families and search for better therapies for people with rare lysosomal storage disorder.

A novel approach to septic shock leads to a prospective new therapy
Journal News

A novel approach to septic shock leads to a prospective new therapy

February 23, 2021

A French research team finds new evidence supporting endotoxin removal for treating life-threatening inflammation.

When scientists become allergic to their research
News

When scientists become allergic to their research

February 21, 2021

Researchers spend long periods of time around the organisms they study. Sometimes, that exposure has unintended effects.

In mice, a mother's love comes from the gut
News

In mice, a mother's love comes from the gut

February 20, 2021

Scientists from the Salk Institute report a new influence on maternal behavior arising from an unexpected source.